Transforming growth factor-α-induced transcriptional activation of the Vascular permeability factor (VPF/VEGF) gene requires AP-2-dependent DNA binding and transactivation

EMBO Journal

Volumn 16, Issue 4, 1997, Pages 750-759

  Gille, Jens ^a   Swerlick, Robert A ^b   Caughman, S Wright ^b  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Gene expression regulation; TGF ; Transcription factors; VEGF; VPF

Indexed keywords

DNA; EPIDERMAL GROWTH FACTOR RECEPTOR; TRANSCRIPTION FACTOR AP 2; TRANSCRIPTION FACTOR SP1; TRANSFORMING GROWTH FACTOR ALPHA; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; ELECTROPHORETIC MOBILITY; EXPRESSION VECTOR; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; KERATINOCYTE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; PSORIASIS; REGULATORY MECHANISM; SKIN INFLAMMATION; TRANSACTIVATION; TRANSCRIPTION INITIATION; WOUND HEALING;

BASE SEQUENCE; CARCINOMA, SQUAMOUS CELL; DNA; DNA-BINDING PROTEINS; EARLY GROWTH RESPONSE PROTEIN 1; ENDOTHELIAL GROWTH FACTORS; HUMANS; IMMEDIATE-EARLY PROTEINS; LYMPHOKINES; PROMOTER REGIONS (GENETICS); RECOMBINANT FUSION PROTEINS; RNA, MESSENGER; SEQUENCE DELETION; SP1 TRANSCRIPTION FACTOR; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTOR AP-2; TRANSCRIPTION FACTORS; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0031039923     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/16.4.750     Document Type: Article

References (70)

1. Aiello, L.P. et al. (1994) Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N. Engl. J. Med., 331, 1480-1487.
2. Azizkhan, J.C., Jensen, D.E., Pierce, A.J. and Wade, M. (1993) Transcription from TATA-less promoters: dihydrofolate reductase as a model. Crit. Rev. Eukaryot. Gene Expr., 3, 229-254.
3. Ballaun, C., Weninger, W., Uthman, A., Weich, H. and Tschachler, E. (1995) Human keratinocytes express the three major splice forms of vascular endothelial growth factor. J. Invest. Dermatol., 104, 7-10.
4. Boukamp, P., Petrussevska, R.T., Breitkreutz, D., Hornung, J., Markham, A. and Fusenig, N.E. (1988) Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J. Cell Biol., 106, 761-771.
5. Brown, L.F., Yeo, K.T., Berse, B., Yeo, J.K., Senger, D.R., Dvorak, H.F. and van de Water, L. (1992) Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing. J. Exp. Med., 176, 1375-1379.
6. Brown, L.F., Harrist, T.J., Yeo, K.T., Stahle-Backdahl, M., Jackman, R.W., Berse, B., Tognazzi, K., Dvorak, H.F. and Detmar, M. (1995a) Increased expression of vascular permeability factor (vascular endothelial growth factor) in bullous pemphigoid, dermatitis herpetiformis, and erythema multiforme. J. Invest. Dermatol., 104, 744-749.
7. Brown, L.F., Olbricht, S.M., Berse, B., Jackman, R.W., Matsueda, G., Tognazzi, K.A., Manseau, E.J., Dvorak, H.F. and van de Water, L. (1995b) Overexpression of vascular permeability factor (VPF/VEGF) and its endothelial cell receptors in delayed hypersensitivity skin reactions. J. Immunol., 154, 2801-2807.
8. Buettner, R., Kannan, P., Imhof, A., Bauer, R., Yim, S.O., Glockshuber, R., Van Dyke, M.W. and Tainsky, M.A. (1993) An alternatively spliced mRNA from the AP-2 gene encodes a negative regulator of transcriptional activation by AP-2. Mol. Cell. Biol., 13, 4174-4185.
9. Claffey, K.P., Brown, L.F., del Aguila, L.F., Tognazzi, K., Yeo, K.T., Manseau, E.J. and Dvorak, H.F. (1996) Expression of vascular permeability factor/vascular endothelial growth factor by melanoma cells increases tumor growth, angiogenesis, and experimental metastasis. Cancer Res., 56, 172-181.
10. Coffey, R.J., Jr. Derynck, R., Wilcox, J.N., Bringman, T.S., Goustin, A.S., Moses, H.L. and Pittelkow, M.R. (1987) Production and auto-induction of transforming growth factor-alpha in human keratinocytes. Nature, 328, 817-820.
11. Derynck, R. (1992) The physiology of transforming growth factor-alpha. Adv. Cancer Res., 58, 27-52.
12. Derynck, R., Goeddel, D.V., Ullrich, A., Gutterman, J.U., Williams, R.D., Bringman, T.S. and Berger, W.H. (1987) Synthesis of messenger RNAs for transforming growth factors alpha and beta and the epidermal growth factor receptor by human tumors. Cancer Res., 47, 707-712.
13. Detmar, M. (1996) Molecular regulation of angiogenesis in the skin. J. Invest. Dermatol., 106, 207-208.
14. Detmar, M., Brown, L.F., Claffey, K.P., Yeo, K.T., Kocher, O., Jackman, R.W., Berse, B. and Dvorak, H.F. (1994) Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis. J. Exp. Med., 180, 1141-1146.
15. Detmar, M., Yeo, K.T., Nagy, J.A., van de Water, L., Brown, L.F., Berse, B., Elicker, B.M., Ledbetter, S. and Dvorak, H.F. (1995) Keratinocyte-derived vascular permeability factor (vascular endothelial growth factor) is a potent mitogen for dermal microvascular endothelial cells. J. Invest. Dermatol., 105, 44-50.
16. De Vries, C., Escobedo, J.A., Ueno, H., Houck, K., Ferrara, N. and Williams, L.T. (1992) The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science, 255, 989-991.
17. Dignam, J.D., Lebovitz, R.M. and Roeder, R.G. (1983) Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res., 11, 1475-1489.
18. Dvorak, H.F., Brown, L.F., Detmar, M. and Dvorak, A.M. (1995) Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am. J. Pathol., 146, 1029-1039.
19. Elder, J.T., Fisher, G.J., Lindquist, P.B., Bennett, G.L., Pittelkow, M.R., Coffey, R.J., Jr, Ellingsworth, L., Derynck, R. and Voorhees, J.J. (1989) Overexpression of transforming growth factor alpha in psoriatic epidermis. Science, 243, 811-814.
20. Ferrara, N., Heinsohn, H., Walder, C.E., Bunting, S. and Thomas, G.R. (1995) The regulation of blood vessel growth by vascular endothelial growth factor. Ann. N. Y. Acad. Sci., 752, 246-256.
21. Folkman, J. (1995) Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Med., 1, 27-31.
22. Folkman, J. and Shing, Y. (1992) Angiogenesis. J. Biol. Chem., 267, 10931-10934.
23. Frank, S., Hubner, G., Breier, G., Longaker, M.T., Greenhalgh, D.G. and Werner, S. (1995) Regulation of vascular endothelial growth factor expression in cultured keratinocytes. Implications for normal and impaired wound healing. J. Biol. Chem., 270, 12607-12613.
24. Gashler, A. and Sukhatme, V.P. (1995) Early growth response protein 1 (Egr-1): prototype of a zinc-finger family of transcription factors. Prog. Nucleic Acid Res. Mol. Biol., 50, 191-224.
25. Gashler, A.L., Swaminathan, S. and Sukhatme, V.P. (1993) A novel repression module, an extensive activation domain, and a bipartite nuclear localization signal defined in the immediate-early transcription factor Egr-1. Mol. Cell. Biol., 13, 4556-4571.
26. Gille, J., Swerlick, R.A., Lawley, T.J. and Caughman, S.W. (1996) Differential regulation of vascular cell adhesion molecule-1 gene transcription by tumor necrosis factor alpha and interleukin-1 alpha in dermal microvascular endothelial cells. Blood, 87, 211-217.
27. Goldman, C.K., Kim, J., Wong, W.L., King, V., Brock, T. and Gillespie, G.Y. (1993) Epidermal growth factor stimulates vascular endothelial growth factor production by human malignant glioma cells: a model of glioblastoma multiforme pathophysiology. Mol. Biol. Cell, 4, 121-133.
28. Ikeda, E., Achen, M.G., Breier, G. and Risau, W. (1995) Hypoxia-induced transcriptional activation and increased mRNA stability of vascular endothelial growth factor in C6 glioma cells. J. Biol. Chem., 270, 19761-19766.
29. Imagawa, M., Chiu, R. and Karin, M. (1987) Transcription factor AP-2 mediates induction by two different signal-transduction pathways: protein kinase C and cAMP. Cell, 51, 251-260.
30. Kim, K.J., Li, B., Winer, J., Armanini, M., Gillett, N., Phillips, H.S. and Ferrara, N. (1993) Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature, 362, 841-844.
31. Koch, A.E., Harlow, L.A., Haines, G.K., Amento, E.P., Unemori, E.N., Wong, W.L., Pope, R.M. and Ferrara, N. (1994) Vascular endothelial growth factor. A cytokine modulating endothelial function in rheumatoid arthritis. J. Immunol., 152, 4149-4156.
32. Krane, J.F., Gottlieb, A.B., Carter, D.M. and Krueger, J.G. (1992) The insulin-like growth factor I receptor is overexpressed in psoriatic epidermis, but is differentially regulated from the epidermal growth factor receptor. J. Exp. Med., 175, 1081-1090.
33. Lee, D.C., Fenton, S.E., Berkowitz, E.A. and Hissong, M.A. (1995) Transforming growth factor alpha: expression, regulation, and biological activities. Pharmacol. Rev., 47, 51-85.
34. Leung, D.W., Cachianes, G., Kuang, W.J., Goeddel, D.V. and Ferrara, N. (1989) Vascular endothelial growth factor is a secreted angiogenic mitogen. Science, 246, 1306-1309.
35. Levy, A.P. Levy, N.S., Wegner, S. and Goldberg, M.A. (1995) Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia. J. Biol. Chem., 270, 13333-13340.
36. Levy, A.P. Levy, N.S. and Goldberg, M.A. (1996) Post-transcriptional regulation of vascular endothelial growth factor by hypoxia. J. Biol. Chem., 271, 2746-2753.
37. Liu, Y., Cox, S.R., Morita, T. and Kourembanas, S. (1995) Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Identification of a 5′ enhancer. Circ. Res., 77, 638-643.
38. Luscher, B., Mitchell, P.J., Williams, T. and Tjian, R. (1989) Regulation of transcription factor AP-2 by the morphogen retinoic acid and by second messengers. Genes Dev., 3, 1507-1517.
39. Maglione, D., Guerriero, V., Viglietto, G., Delli-Bovi, P. and Persico, M.G. (1991) Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. Proc. Natl Acad. Sci. USA, 88, 9267-9271.
40. Mercham, J.L., Demediuk, B. and Brand, S.J. (1991) A GC-rich element confers epidermal growth factor responsiveness to transcription from the gastrin promoter. Mol. Cell. Biol., 11, 2686-2696.
41. Millauer, B., Shawver, L.K., Plate, K.H., Risau, W. and Ullrich, A. (1994) Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant. Nature, 367, 576-579.
42. Minchenko, A., Salceda, S., Bauer, T. and Caro, J. (1994) Hypoxia regulatory elements of the human vascular endothelial growth factor gene. Cell. Mol. Biol. Res., 40, 35-39.
43. Moser, M., Imhof, A., Pscherer, A., Bauer, R., Amselgruber, W., Sinowatz, F., Hofstadter, F., Schule, R. and Buettner, R. (1995) Cloning and characterization of a second AP-2 transcription factor: AP-2 beta. Development, 121, 2779-2788.
44. Mustonen, T. and Alitalo, K. (1995) Endothelial receptor tyrosine kinases involved in angiogenesis. J. Cell Biol., 129, 895-898.
45. Myoken, Y., Kayada, Y., Okamoto, T., Kan, M., Sato, G.H. and Sato, J.D. (1991) Vascular endothelial cell growth factor (VEGF) produced by A-431 human epidermoid carcinoma cells and identification of VEGF membrane binding sites. Proc. Natl Acad. Sci. USA, 88, 5819-5823.
46. Ono, I., Gunji, H., Suda, K., Iwatsuki, K. and Kaneko, F. (1994) Evaluation of cytokines in donor site wound fluids. Scand. J. Plast. Reconstr. Surg. Hand Surg., 28, 269-273.
47. Pepper, M.S., Ferrara, N., Orci, L. and Montesano, R. (1992) Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro. Biochem. Biophys. Res. Commun., 189, 824-831.
48. Plate, K.H., Breier, G. and Risau, W. (1994) Molecular mechanisms of developmental and tumor angiogenesis. Brain Pathol., 4, 207-218.
49. Plouet, J., Schilling, J. and Gospodarowicz, D. (1989) Isolation and characterization of a newly identified endothelial cell mitogen produced by AtT-20 cells. EMBO J., 8, 3801-3806.
50. Potgens, A.J., Lubsen, N.H., van Altena, M.C., Schoenmakers, J.G., Ruiter, D.J. and de Waal, R.M. (1995) Vascular permeability factor expression influences tumor angiogenesis in human melanoma lines xenografted to nude mice. Am. J. Pathol., 146, 197-209.
51. Quinn, T.P., Peters, K.G., De Vries, C., Ferrara, N. and Williams, L.T. (1993) Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium. Proc. Natl Acad. Sci. USA, 90, 7533-7537.
52. Roberts, W.G. and Palade, G.E. (1995) Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. J. Cell Sci., 108, 2369-2379.
53. Sambrook, J., Fritsch, E.F. and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
54. Schreiber, A.B., Winkler, M.E. and Derynck, R. (1986) Transforming growth factor-alpha: a more potent angiogenic mediator than epidermal growth factor. Science, 232, 1250-1253.
55. Schultz, G., Rotatori, D.S. and Clark, W. (1991) EGF and TGF-alpha in wound healing and repair. J. Cell. Biochem., 45, 346-352.
56. Seetharam, L., Gotoh, N., Maru, Y., Neufeld, G., Yamaguchi, S. and Shibuya, M. (1995) A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor VEGF. Oncogene, 10, 135-147.
57. Senger, D.R., Galli, S.J., Dvorak, A.M., Perruzzi, C.A., Harvey, V.S. and Dvorak, H.F. (1983) Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science, 219, 983-985.
58. Senger, D.R., Perruzzi, C.A., Feder, J. and Dvorak, H.F. (1986) A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines. Cancer Res., 46, 5629-5632.
59. Senger, D.R., Brown, L.F., Claffey, K.P. and Dvorak, H.F. (1994) Vascular permeability factor, tumor angiogenesis and stroma generation. Invasion Metastasis. 14, 385-394.
60. Shibuya, M. (1995) Role of VEGF-flt receptor system in normal and tumor angiogenesis. Adv. Cancer Res., 67, 281-316.
61. Sioussat, T.M., Dvorak, H.F., Brock, T.A. and Senger, D.R. (1993) Inhibition of vascular permeability factor (vascular endothelial growth factor) with antipeptide antibodies. Arch. Biochem. Biophys., 301, 15-20.
62. Stein, I., Neeman, M., Shweiki, D., Itin, A. and Keshet, E. (1995) Stabilization of vascular endothelial growth factor mRNA by hypoxia and hypoglycemia and coregulation with other ischemia-induced genes. Mol. Cell. Biol., 15, 5363-5368.
63. Stoscheck, C.M., Nanney, L.B. and King, L.E., Jr (1992) Quantitative determination of EGF-R during epidermal wound healing. J. Invest. Dermatol., 99, 645-649.
64. Terman, B.I., Dougher-Vermazen, M., Carrion, M.E., Dimitrov, D., Armellino, D.C., Gospodarowicz, D. and Bohlen, P. (1992) Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochem. Biophys. Res. Commun., 187, 1579-1586.
65. Thomas, K.A. (1996) Vascular endothelial growth factor, a potent and selective angiogenic agent. J. Biol. Chem., 271, 603-606.
66. Tischer, E., Gospodarowicz, D., Mitchell, R., Silva, M., Schilling, J., Lau, K., Crisp, T., Fiddes, J.C. and Abraham, J.A. (1989) Vascular endothelial growth factor: a new member of the platelet-derived growth factor gene family. Biochem. Biophys. Res. Commun., 165, 1198-1206.
67. Tischer, E., Mitchell, R., Hartman, T., Silva, M., Gospodarowicz, D., Fiddes, J.C. and Abraham, J.A. (1991) The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J. Biol. Chem., 266, 11947-11954.
68. Watts, P., Stables, G.S., Akhurst, R.J. and Mackie, R.M. (1994) Localization of transforming growth factor-alpha RNA and protein in the skin of psoriatic patients receiving therapy. Br. J. Dermatol., 131, 64-71.
69. Williams, T. and Tjian, R. (1991) Analysis of the DNA-binding and activation properties of the human transcription factor AP-2. Genes Dev., 5, 670-682.
70. Williams, T., Admon, A., Luscher, B. and Tjian, R. (1988) Cloning and expression of AP-2, a cell-type-specific transcription factor that activates inducible enhancer elements. Genes Dev., 2, 1557-1569.